Protalix: Elfabrio’s Clinical Edge Supports Reiterated Buy Rating and $12 Price Target
at www.tipranks.com (Wed, 4-Nov 7:26 AM)
Protalix Posts Record Revenue Growth and Achieves Profitability, Backed by Strong Pipeline Progress
Market Chameleon (Wed, 12-Aug 11:55 AM)
